Influence of the amount of skeletal muscle mass on rocuronium-induced neuromuscular block
Open Access
- 28 April 2022
- journal article
- research article
- Published by Elsevier in Anaesthesia Critical Care & Pain Medicine
- Vol. 41 (4) , 101086
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Should Dosing of Rocuronium in Obese Patients Be Based on Ideal or Corrected Body Weight?Anesthesia & Analgesia, 2009
- The neuromuscular effects of 0.6 mg kg−1 rocuronium in elderly and young adults with or without renal failure*European Journal of Anaesthesiology, 2008
- Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortalityEuropean Heart Journal, 2008
- The Pharmacodynamic Effects of Rocuronium When Dosed According to Real Body Weight or Ideal Body Weight in Morbidly Obese PatientsAnesthesia & Analgesia, 2004
- Pharmacokinetics of rocuronium bromide in obese female patientsEuropean Journal of Anaesthesiology, 1999
- A large simple randomized trial of rocuronium versus succinylcholine in rapid‐sequence induction of anaesthesia along with propofolActa Anaesthesiologica Scandinavica, 1999
- Dose-Ranging Study in Younger Adult and Elderly Patients of ORG 9487, a New, Rapid-Onset, Short-Duration Muscle RelaxantAnesthesia & Analgesia, 1997
- Clinical Pharmacokinetics of Rocuronium BromideClinical Pharmacokinetics, 1996
- Pharmacokinetics and Pharmacodynamics of Rocuronium (Org 9426) in Elderly Surgical PatientsAnesthesia & Analgesia, 1993
- Pharmacodynamic behaviour of rocuronium in the elderlyCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1993